Skip to main content

Table 1 Summary of hepatic metastasectomy from selected studies

From: Oligometastasis and oligo-recurrence: more than a mirage

Primary tumor type

Year

No. patients

5-year survival (%)

10-year survival (%)

References

Noncolorectal

2005

142

26

/

[16]

Noncolorectal Nonendocrine liver metastases

2006

1452

36

23

[17]

Noncolorectal nonneuroendocrine liver metastases

2007

360

37

/

[18]

Breast cancer

2010

41

48

/

[19]

Soft-tissue sarcoma

2009

45

49

/

[20]